MGN 17xx series - Mologen

Drug Profile

MGN 17xx series - Mologen

Alternative Names: MGN-1706; MGN-17xx

Latest Information Update: 12 Feb 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Mologen
  • Class
  • Mechanism of Action Immunomodulators; Toll-like receptor 9 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 12 Feb 2014 No development reported - Phase-I for Cancer in Germany (SC)
  • 17 Jan 2011 Phase I development in Cancer is ongoing in Germany
  • 30 Jan 2009 Phase-I clinical trials in Prostate cancer in Germany (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top